XXXII International Congress of the World Federation of Hemophilia (WFH)
Event Date: July 24 - 28, 2016
Event Location: Gaylord Palms Resort & Convention Center, Orlando, FL
The XXXII International Congress of the World Federation of Hemophilia (WFH) is expected to be the largest in the WFH’s history, with more than 6,000 attendees expected from over 125 countries. The WFH 2016 World Congress will be held right after National Hemophilia Foundation’s (NHF) 68th Annual Meeting. The NHF will host the largest international meeting dedicated to hemophilia, von Willebrand disease, rare factor deficiencies, and inherited platelet disorders since it is the first time in over 25 years that the global community meets in the United States. This will be a unique opportunity for US healthcare providers, NHF chapters, as well as patients and their families to join the global bleeding disorders community.
Congress attendees include hematologists, pediatricians, orthopedic surgeons, geneticists, laboratory technicians, researchers, and scientists who represent the comprehensive care team for people with bleeding disorders. The WFH 2016 World Congress is also the global meeting place for national patient organization leaders, as well as people with bleeding disorders and their families. Presentations, workshops, symposia, and exhibits will feature cutting-edge trends in research and treatment for hemophilia and other inherited bleeding disorders.
About the WFH
The World Federation of Hemophilia (WFH) is an international non-profit organization dedicated to improving the lives of people with hemophilia and other genetic bleeding disorders. It educates hemophiliacs and lobbies for improved medical treatment. 75% of people in the world with bleeding disorders do not know it and do not receive care.
WFH, Twitter, Facebook, YouTube, Gaylord Palms Resort & Convention Center
About the National Hemophilia Foundation’s (NHF)
The National Hemophilia Foundation (NHF) is dedicated to finding better treatments and cures for inheritable bleeding disorders and to preventing the complications of these disorders through education, advocacy and research.